Coloplast A/S Cash Flow Conversion Efficiency
Coloplast A/S cash flow conversion efficiency. Based on the latest financial reports, Coloplast A/S (COLO-B) has a cash flow conversion efficiency ratio of 0.162x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr2.23 Billion ≈ $349.37 Million USD) by net assets (Dkr13.80 Billion ≈ $2.16 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Coloplast A/S (2002–2025)
Cash flow conversion efficiency of Coloplast A/S from 2002 to 2025. This chart illustrates how Coloplast A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Coloplast A/S stock price for real-time trading data and today's change.
Coloplast A/S Cash Flow Conversion Ratio Explained
Coloplast A/S cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Coloplast A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Coloplast A/S ranked by their cash flow conversion efficiency. Also see market cap of Coloplast A/S for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ASSOC. BR. FOODS ADR 1
F:AFO2
|
N/A |
|
EMS-CHEMIE HOLDING AG
SW:EMSN
|
0.181x |
|
Fuyao Glass Industry Group Co Ltd Class A
SHG:600660
|
0.065x |
|
Samsara Inc
NYSE:IOT
|
0.054x |
|
Zangge Holding Co Ltd
SHE:000408
|
0.044x |
|
Hangzhou Chang Chuan Technology Co Ltd
SHE:300604
|
0.036x |
|
Stanley Black & Decker Inc
NYSE:SWK
|
0.085x |
|
GF Securities Co Ltd
SHE:000776
|
0.061x |
Annual Cash Flow Conversion Efficiency for Coloplast A/S (2002–2025)
The table below shows the annual cash flow conversion efficiency of Coloplast A/S from 2002 to 2025. Review COLO-B FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Dkr16.12 Billion ≈ $2.52 Billion |
Dkr6.64 Billion ≈ $1.04 Billion |
0.412x | +167.36% |
| 2024-09-30 | Dkr17.94 Billion ≈ $2.81 Billion |
Dkr2.77 Billion ≈ $432.76 Million |
0.154x | -36.89% |
| 2023-09-30 | Dkr17.30 Billion ≈ $2.71 Billion |
Dkr4.23 Billion ≈ $661.19 Million |
0.244x | -60.27% |
| 2022-09-30 | Dkr8.29 Billion ≈ $1.30 Billion |
Dkr5.10 Billion ≈ $797.78 Million |
0.615x | -5.05% |
| 2021-09-30 | Dkr8.17 Billion ≈ $1.28 Billion |
Dkr5.29 Billion ≈ $827.66 Million |
0.648x | +0.79% |
| 2020-09-30 | Dkr7.41 Billion ≈ $1.16 Billion |
Dkr4.76 Billion ≈ $744.58 Million |
0.643x | +1.96% |
| 2019-09-30 | Dkr6.91 Billion ≈ $1.08 Billion |
Dkr4.36 Billion ≈ $681.68 Million |
0.630x | -7.25% |
| 2018-09-30 | Dkr6.42 Billion ≈ $1.00 Billion |
Dkr4.36 Billion ≈ $682.31 Million |
0.679x | +24.40% |
| 2017-09-30 | Dkr5.95 Billion ≈ $931.23 Million |
Dkr3.25 Billion ≈ $508.64 Million |
0.546x | -8.58% |
| 2016-09-30 | Dkr5.07 Billion ≈ $792.93 Million |
Dkr3.03 Billion ≈ $473.75 Million |
0.597x | -15.74% |
| 2015-09-30 | Dkr4.71 Billion ≈ $736.29 Million |
Dkr3.34 Billion ≈ $522.10 Million |
0.709x | +41.48% |
| 2014-09-30 | Dkr6.28 Billion ≈ $983.02 Million |
Dkr3.15 Billion ≈ $492.68 Million |
0.501x | +8.18% |
| 2013-09-30 | Dkr6.77 Billion ≈ $1.06 Billion |
Dkr3.14 Billion ≈ $490.65 Million |
0.463x | +5.67% |
| 2012-09-30 | Dkr6.04 Billion ≈ $945.31 Million |
Dkr2.65 Billion ≈ $414.46 Million |
0.438x | -10.96% |
| 2011-09-30 | Dkr4.48 Billion ≈ $700.62 Million |
Dkr2.21 Billion ≈ $344.99 Million |
0.492x | -3.91% |
| 2010-09-30 | Dkr3.45 Billion ≈ $540.09 Million |
Dkr1.77 Billion ≈ $276.77 Million |
0.512x | -20.19% |
| 2009-09-30 | Dkr2.85 Billion ≈ $445.90 Million |
Dkr1.83 Billion ≈ $286.32 Million |
0.642x | +11.11% |
| 2008-09-30 | Dkr2.29 Billion ≈ $358.44 Million |
Dkr1.32 Billion ≈ $207.15 Million |
0.578x | +38.15% |
| 2007-09-30 | Dkr2.40 Billion ≈ $375.50 Million |
Dkr1.00 Billion ≈ $157.08 Million |
0.418x | +21.47% |
| 2006-09-30 | Dkr2.81 Billion ≈ $438.86 Million |
Dkr966.00 Million ≈ $151.14 Million |
0.344x | -36.01% |
| 2005-09-30 | Dkr2.51 Billion ≈ $393.33 Million |
Dkr1.35 Billion ≈ $211.69 Million |
0.538x | +51.45% |
| 2004-09-30 | Dkr2.37 Billion ≈ $370.25 Million |
Dkr840.90 Million ≈ $131.57 Million |
0.355x | -21.60% |
| 2003-09-30 | Dkr2.01 Billion ≈ $314.48 Million |
Dkr911.00 Million ≈ $142.53 Million |
0.453x | -22.11% |
| 2002-09-30 | Dkr1.57 Billion ≈ $245.48 Million |
Dkr913.00 Million ≈ $142.85 Million |
0.582x | -- |
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more